Examinando por Autor "Vivas-Fernandez, Manuel"
Mostrando 1 - 5 de 5
- Resultados por página
- Opciones de ordenación
Ítem A 12‑Month Follow‑Up of PROCARE+, a Transdiagnostic, Selective, Preventive Intervention for Adolescents At‑Risk for Emotional Disorders(2023) Vivas-Fernandez, Manuel; Garcia-Lopez, Luis J.; Piqueras, Jose A.; Espinosa-Fernandez, Lourdes; Muela-Martinez, Jose A.; Jimenez-Vazquez, David; Diaz-Castela, M. Mar; Ehrenreich-May, JillFew studies have reported long-term follow-up data on selective preventive interventions for adolescents. No follow-up selective preventive transdiagnostic studies for adolescents at-risk for emotional disorders, such as anxiety and depression, have been reported. To fill this gap, this study aims to provide the first follow-up assessment of a randomized controlled trial (RCT) studying selective transdiagnostic prevention in at-risk adolescents. A 12-month follow-up assessment was conducted with subjects who originally received either PROCARE (Preventive transdiagnostic intervention for Adolescents at Risk for Emotional disorders), PROCARE+, which includes the PROCARE protocol along with personalized add-on modules or an active control condition (ACC) based on emotional psychoeducation, and their respective booster session for each experimental condition. 80 subjects (47.5% girls) aged between 12 and 18 years (M = 14.62; SD 1.43) who completed these treatment conditions were available for the 12-month follow-up. The results demonstrate the superior long-term efficacy of the PROCARE+ intervention in mitigating emotional symptoms and obsessive–compulsive symptomatology compared to the PROCARE and ACC conditions, with effect sizes notably exceeding those commonly observed in preventive programs. While the three treatments demonstrated beneficial impacts, the pronounced results associated with PROCARE+ at the 12-month follow-up emphasized the importance of personalized treatment modules and the sustained benefits of booster sessions in the realm of preventive psychological interventions. The findings also highlight the potential role of add-on modules in enhancing the effects of the PROCARE+ condition.Ítem Effectiveness of a transdiagnostic indicated preventive intervention for adolescents at high risk for anxiety and depressive disorders(2023) Garcia-Lopez, Luis J.; Jimenez-Vazquez, David; Muela-Martinez, Jose A.; Piqueras, Jose A.; Espinosa-Fernandez, Lourdes; Canals-Sans, Josefa; Vivas-Fernandez, Manuel; Morales-Hidalgo, Paula; Diaz-Castela, M. Mar; Rivera, M; Ehrenreich-May, JillDespite ample evidence for transdiagnostic interventions in clinical populations and in universal prevention approaches, there are only a few controlled trials examining their role for indicated prevention. This study is the first randomized controlled trial to assess the effectiveness of a brief, 8-session group version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A), called PROCARE-I (Preventive Transdiagnostic Intervention for Adolescents at Risk for Emotional Disorders-Indicated), delivered online, and including a booster session, in reducing symptoms of anxiety and depression in adolescents compared to an active control condition. Sixty-four adolescents (53% identifying as female) with elevated levels of anxiety and/or depression were randomly assigned to either the 8-week PROCARE-I or the active control condition. Self-report, parent, and clinician measures were collected before and after the interventions, at the 6-month followup, and 1 month after the booster session. After the intervention, participants in the PROCARE-I group showed improved scores on 9 of the 13 primary and secondary outcome measures, including reduction of anxiety and mood symptomatology, level of risk of developing emotional disorders, resilience, as well as increase of psychological flexibility, and emotional regulation. In contrast, those in the control group showed improvements in only 2 of the 13 outcome measures. After the booster session, significant differences were found between the PROCARE-I and control condition on measures of overall anxiety and depression symptoms, emotional risk, resilience, and quality of life. Low dropout rates and limited incidence of emotional disorders were observed at follow-ups. The interventions were well-accepted, with high satisfaction rates.Ítem Effectiveness of a transdiagnostic indicated preventive intervention for adolescents at high risk for anxiety and depressive disorders(Springer Nature, 2023-12-14) Garcia-Lopez, Luis Joaquin; Jimenez-Vazquez, David; Muela-Martinez, José Antonio; Piqueras, José A.; Espinosa-Fernández, Lourdes; Canals-Sans, Josefa; Vivas-Fernandez, Manuel; Morales-Hidalgo, Paula; Diaz-Castela, María-Mar; Rivera, MaríaDespite ample evidence for transdiagnostic interventions in clinical populations and in universal prevention approaches, there are only a few controlled trials examining their role for indicated prevention. This study is the first randomized controlled trial to assess the effectiveness of a brief, 8-session group version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A), called PROCARE-I (Preventive Transdiagnostic Intervention for Adolescents at Risk for Emotional Disorders-Indicated), delivered online, and including a booster session, in reducing symptoms of anxiety and depression in adolescents compared to an active control condition. Sixty-four adolescents (53% identifying as female) with elevated levels of anxiety and/or depression were randomly assigned to either the 8-week PROCARE-I or the active control condition. Self-report, parent, and clinician measures were collected before and after the interventions, at the 6-month follow-up, and 1 month after the booster session. After the intervention, participants in the PROCARE-I group showed improved scores on 9 of the 13 primary and secondary outcome measures, including reduction of anxiety and mood symptomatology, level of risk of developing emotional disorders, resilience, as well as increase of psychological flexibility, and emotional regulation. In contrast, those in the control group showed improvements in only 2 of the 13 outcome measures. After the booster session, significant differences were found between the PROCARE-I and control condition on measures of overall anxiety and depression symptoms, emotional risk, resilience, and quality of life. Low dropout rates and limited incidence of emotional disorders were observed at follow-ups. The interventions were well-accepted, with high satisfaction rates.Ítem Exploring the Role of Resilience as a Mediator in Selective Preventive Transdiagnostic Intervention (PROCARE+) for Adolescents at Risk of Emotional Disorders(Hogrefe, 2024-04-25) Vivas-Fernandez, Manuel; Garcia-Lopez, Luis Joaquin; Muela-Martinez, José Antonio; Piqueras, José A.; Espinosa-Fernández, Lourdes; Jimenez-Vazquez, David; Diaz-Castela, María del MarIntroduction: Psychological treatments are becoming an increasingly important component of medical healthcare, as a growingnumber of people seek treatment for a wide range of mental health problems. While these treatments are known to be effective, much remainsto be understood about their mechanisms and reasons for effectiveness. The study of statistical mediators is crucial in psychological research,as it is fundamental to understanding how psychological factors influence health, well-being, and human behavior, and thus to designingeffective psychological interventions. Aim: This study investigates the role of resilience as a treatment mediator in PROCARE+, a brieftransdiagnostic, personalized protocol for the selective prevention of emotional disorders in adolescents. This approach has proven effectivefor young people at risk of developing emotional issues. Method: We used simple mediation models in a sample of 153 adolescents to assessthe impact of interventions on resilience. Outcome variables included self-reported and parent-reported emotional risk, mood, anxietysymptoms, and quality of life. Discussion: The results of this study provide valuable information on how PROCARE+ works and how to improveits effectiveness, pointing to resilience as a key mediator in reducing the risk of developing emotional disorders and improving quality of life.Ítem Randomized controlled trial for selective preventive transdiagnostic intervention for adolescents at risk for emotional disorders(2023) Vivas-Fernandez, Manuel; Garcia-Lopez, Luis J.; Piqueras, Jose A.; Muela-Martinez, Jose A.; Canals-Sans, Josefa; Espinosa-Fernandez, Lourdes; Jimenez-Vazquez, David; Diaz-Castela, M. Mar; Morales-Hidalgo, Paula; Rivera, Maria; Ehrenreich-May, JillSignificant evidence does exist on the effectiveness of transdiagnostic interventions to improve emotional problems in clinical populations, and their application as universal and indicated prevention programs. However, no randomized controlled trials (RCT) studying selective transdiagnostic prevention intervention have been published. This is the first known RCT to evaluate the efficacy/effectiveness of an evidence-based selective prevention transdiagnostic program for emotional problems in adolescents. The impact of three different interventions was evaluated: (1) PROCARE (Preventive transdiagnostic intervention for Adolescents at Risk for Emotional disorders), which is a group-based, abbreviated version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A), along with adding a booster session to reduce risk of onset of anxiety and depression, (2) PROCARE + , which includes the PROCARE protocol along with personalized add-on modules tailored to match adolescents’ risk factors, and (3) an active control condition (ACC) based on emotional psychoeducation. In total, 208 adolescents (48.5% girls) evidencing high risk and low protective factors were randomized and allocated to PROCARE, PROCARE + or ACC. Data from 153 adolescents who completed all assessments in the different phases of the study were analyzed. Self- and parent-reported measures were taken at baseline, as well as after the intervention, a 6 month follow-up was carried out, together with a 1 month follow-up after the booster session. Differences between conditions were significant on most of the outcome measures, with superior effect sizes for PROCARE + in the short and long term. Interventions were acceptable in terms of acceptability, with good satisfaction rates. Tailored targeted selective transdiagnostic interventions focused on mitigating risk factors and promoting protective factors in vulnerable adolescents are promising.